The latest type 2 diabetes (T2D) management guidance from the American Association of Clinical Endocrinology (AACE) covers ...

Novo Nordisk (NVO) stock gains after oral semaglutide pill succeeds in pediatric type 2 diabetes trial. Company targets H2 ...

April 23 (Reuters) - Novo Nordisk's oral GLP-1 drug significantly lowered blood sugar levels in children and adolescents with ...

Best known as a type 2 diabetes treatment, metformin is also being investigated for its possible effects on PCOS and ageing.

As technology becomes more integrated and personalized, experts say the biggest opportunity in diabetes management is ...

Novo Nordisk's oral GLP-1 pill achieved its main target in a late-stage diabetes study involving children and adolescents ...

I took a round-trip flight on Emirates, experiencing both First Class and their newly upgraded Business Class on a Boeing 777 ...

Novo Nordisk’s oral GLP-1 therapy significantly lowered blood sugar in children and adolescents with type 2 diabetes in a late-stage trial, marking the first study of this drug class in the age group.

Twelve million people lost coverage for Zepbound over the last year. The same number of people lost coverage for Wegovy, ...

Pfizer's GLP-1 weight management drug Xianweiying is now available for pre-order in China, signaling rising competition in a ...

All 4 T1D participants receiving SAB-142 showed C-peptide preservation with 3 of the 4 participants showing a super responder ...

The dietitian and behavioral health consultant at Fox Army Health Center are collaborating on three classes that give beneficiaries a holistic perspective for hypertension, diabetes and menopause/peri ...